$1.97 0.01 (+0.51%)
11/27/2009 12:48 PM

Threshold Pharmaceuticals, Inc. (THLD)

CAPS Rating: No stars

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Results 1 - 4 of 4

Recs

0
Member Avatar polvo23 (< 20) Submitted: 2/11/2007 7:51:58 PM : Outperform Start Price: $3.31 THLD Score: -21.28

phase 3...did all the research

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar epocrates (< 20) Submitted: 2/2/2007 10:47:48 AM : Underperform Start Price: $3.48 THLD Score: +23.70

Pancreatic cancer is hard to show survival. Refractory pancreatic cancer is impossible to survival.

Report this Post 0 Comments | Reply | Permalink

Recs

2
Member Avatar Rhondalo (< 20) Submitted: 12/29/2006 11:45:56 AM : Outperform Start Price: $3.72 THLD Score: -28.92

Trials look positive for pancreatic cancer and they may resume clinical research for prostate cancer.

Report this Post 0 Comments | Reply | Permalink

Recs

2
Member Avatar pwlkrphllp (67.00) Submitted: 12/29/2006 2:36:46 AM : Outperform Start Price: $4.11 THLD Score: -33.94

cancer

Report this Post 0 Comments | Reply | Permalink
Results 1 - 4 of 4

Featured Broker Partners